
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Feb. 26, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Feb. 26, 2024
Language: Английский
Bioscientia Medicina Journal of Biomedicine and Translational Research, Journal Year: 2024, Volume and Issue: 8(8), P. 4682 - 4696
Published: May 20, 2024
The aging process is an inevitable occurrence that involves physiological changes at the cellular level. presence of intrinsic and extrinsic stressors can cause damage, leading to senescence premature aging. Senescent cells undergo activation p53/p21 p16INK4a pathways, induce cell cycle arrest, increased expression senescence-associated beta-galactosidase (SA-β-Gal), secretion SASP (senescence-associated secretory phenotype), "inflamm-aging" or chronic inflammation associated with senescence. These “inflamm-aging” accelerates age-related diseases, one which atherosclerosis. relationship between aging, senescence, atherosclerosis has been a focus research on pathogenesis, prevention, therapy. Recent emphasized crucial role senolytics, compounds agents capable eliminating senescent cells, in inhibiting progression slowing down Obtaining more comprehensive understanding processes effectiveness senolytics should facilitate development potent medicines mitigate side effects management cardiovascular disease extend longevity.
Language: Английский
Citations
1Aging and Disease, Journal Year: 2024, Volume and Issue: unknown, P. 0 - 0
Published: Jan. 1, 2024
Rheumatoid arthritis (RA) is an autoimmune disease that affects the living quality of patients, especially elderly population. RA-related morbidity and mortality increase significantly with age, while current clinical drugs for RA are far from satisfactory may have serious side effects. Therefore, development new higher biosafety efficacy demanding. Black phosphorus nanosheets (BPNSs) been widely studied because their excellent biocompatibility. Here, we focus on inherent bioactivity BPNSs, report potential BPNSs as a therapeutic drug elucidate underlying mechanism. We find inhibit autophagy at early stage via AMPK-mTOR pathway, switch energy metabolic pathway to oxidative phosphorylation, intracellular ATP levels, suppress apoptosis, reduce inflammation stress, down-regulate senescence-associated secretory phenotype (SASP)-related genes in rheumatoid synovial fibroblasts (RA-SFs). Further, induce apoptosis macrophages promote transition M1 M2 by regulating related cytokines. Significantly, administration can alleviate key pathological features mice, revealing great potential. This study provides novel option treating RA, emerging promising candidate.
Language: Английский
Citations
1Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15
Published: Dec. 5, 2024
Cellular senescence is a condition characterized by stable, irreversible cell cycle arrest linked to the aging process. The accumulation of senescent cells in cardiac muscle can contribute various cardiovascular diseases (CVD). Telomere shortening, epigenetic modifications, DNA damage, mitochondrial dysfunction, and oxidative stress are known contributors onset cellular heart. link between processes contributed age-related decline function. These include changes functions behaviours that arise from factors, including impaired dynamics, dysregulated biogenesis, mitophagy, (mtDNA), reduced respiratory capacity, structural changes. Thus, regulation biology has role function hearts. Targeting may provide novel therapeutic approach for treating preventing CVD associated with aging. CYP epoxygenases metabolize N-3 N-6 polyunsaturated fatty acids (PUFA) into epoxylipids readily hydrolyzed diol products soluble epoxide hydrolase (sEH). Increasing levels or inhibition sEH demonstrated protective effects Evidence suggests they play regulating mitochondria, thus reducing adverse In this review, we discuss how mitochondria induce affect process aged
Language: Английский
Citations
1AJP Heart and Circulatory Physiology, Journal Year: 2024, Volume and Issue: 326(3), P. H832 - H844
Published: Feb. 2, 2024
Cardiac aging is a multifaceted process that encompasses structural and functional alterations culminating in heart failure. As the elderly population continues to expand, there growing urgent need for interventions combat age-related cardiac decline. Noncoding RNAs have emerged as critical regulators of cellular biochemical processes underlying disease. This review summarizes our current understanding how noncoding function during aging, with particular emphasis on mechanisms RNA modification control their activity. Targeting potential novel therapeutics also discussed.
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Feb. 26, 2024
Language: Английский
Citations
0